The American Art Materials Labeling Act (LHAMA), which came into effect in 1999, stipulates that all art materials sold in the Northland market must be chronically toxic in accordance with the Act.

Even if the art material is not chronically toxic, the logo "Conform to ASTMd4236" (in compliance with ASTMd4236) should be printed on the packaging and products.

LHAMA has come into effect in 1999 and stipulates that all art materials sold in the U.S. market must be chronically toxic in accordance with the requirements of the Act. These art materials include crayons, pencils, chalks, inks, glues, paints, canvases and other common stationery supplies.

The decree requires toxicologists to be accredited by the American Society of Toxicologists (ABT). Manufacturers or repackagers of art materials should provide ABT toxicology specialists with ingredient formulations for art materials to analyze for chronic adverse health effects.

In order to implement the Hazardous Art Materials Labeling Act (LHAMA), the US Consumer Product Safety Commission (CPSC) issued a law on October 9, 1992, and ASTMd4236 was approved as the mandatory standard for LHAMA testing.

Regarding the definition of art materials, on February 13, 1995, CPSC issued a legal document to define art materials:

(1) Pencils, pens, markers, chalks, etc. that can be used for general purposes but not necessarily only for art;

(2) Ancillary tools and devices used in artistic creation;

(3) Surface materials such as colored books and canvases.

However, whether it is defined as an art material does not only depend on the product itself. The CPSC will consider multiple factors when determining whether it is an art material: including packaging, market ownership and sales area. On the other hand, as of August 13, 1995, whether paints, crayons, colored pencils, glues, etc. are sold as part of a craft, model, or collectible, or sold separately, as long as they can be used in art, craft, model or On collectibles, the CPSC will enforce LAHMA requirements on them.

After an accredited ABT toxicologist has performed art materials, if the product has the potential to cause chronic adverse health effects, LHAMA stipulates that the following identification must be made:

(1) There is a word of warning;

(2) a statement of potential danger;

(3) The name of the chronic dangerous ingredient;

(4) Instructions for safe handling;

(5) The name of the allergic ingredient;

(6) Access to health information;

(7) If necessary, more detailed technical data should be added to the supplementary document

I89273O8I27 Zhang Sheng